The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
